5- and 6-membered heterocyclic compounds which are inhibitors of phosphodiesterase 10 are described as are processes, pharmaceutical compositions, pharmaceutical preparations and pharmaceutical use of the compounds in the treatment of mammals, including human(s) for central nervous system (CNS) disorders and other disorders which may affect CNS function. Also described is the treatment of neurological, neurodegenerative and psychiatric disorders including but not limited to those comparing cognitive deficits or schizophrenic symptoms.
本文描述了5-和6-成员
杂环化合物,它们是
磷酸二酯酶10的
抑制剂,以及这些化合物在治疗哺乳动物(包括人类)的中枢神经系统(CNS)疾病和其他可能影响CNS功能的疾病中的过程、制药组合物、制药制剂和制药用途。还描述了治疗神经、神经退行性和精神障碍,包括但不限于那些比较认知缺陷或精神分裂症状的方法。